2014

2014 Grants Awarded
T cell Immunotheraphy for Pseudomyxoma Peritonei
Dr. Steven Katz of Roger Williams Medical Center, Providence, RI and Dr. Cherif Nazmy Boutros of the University of Maryland School of Medicine, Baltimore, MD.
$50,000/2-year
Awarded in memory of Doug Selmont, Keith Surges, Gail Arakelian, Daniel Cuoco, Robert McGee, Connie Grigsby, Linda Granbois, Kathleen DeFelice, Frances Lewis, and Stephen Costello
Update from Drs. Katz & Boutros dated 01-2016
Update from Drs. Katz & Boutros dated 07-2016
Update from Drs. Katz & Boutros dated 01-2017
Update from Drs. Katz & Boutros dated 08-2017
Associated Publication: “Regional CAR-T cell infusions for peritoneal carcinomatosis are superior to systemic delivery.” (Cancer Gene Ther. 2016 May; 23(5): 142–148.)

Targeted Parallel Pathway Blockade as a Treatment Option for Pseudomyxoma Peritonei” Dr. Venkatesh Govindarajan of Creighton University, Omaha, NE.
$50,000/2-year
Awarded in memory of Jim Disney, Barb Serbu, Denise Cannon, Bill Patchak, Patty McGroarty, Vincent Montagna, Frank Loughry, George Sheaffer, and Thomas Murphy
Updates from Dr. Venkatesh Govindarajan dated 2015-2017
Associated Publication: “Bilateral blockade of MEK- and PI3K-mediated pathways downstream of mutant KRAS as a treatment approach for peritoneal mucinous malignancies” (PLoS One. 2017; 12(6): e0179510)